Document Detail

NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis.
MedLine Citation:
PMID:  22106016     Owner:  NLM     Status:  Publisher    
BackgroundMetabolomics could provide new insights into the pathophysiology of cystic fibrosis (CF) by identifying profiles of endogenous metabolites.ObjectivesTo investigate whether metabolomics of exhaled breath condensate could discriminate between patients with unstable CF, stable CF and healthy subjects, and whether selected metabolites were responsible for between-group differences.MethodsTwenty-nine patients with stable CF, 24 with unstable CF and 31 healthy subjects (age 9-24 years) participated in a cross-sectional study. Metabolomics was performed with high-resolution nuclear magnetic resonance spectroscopy. Partial least squares-discriminant analysis was used as classifier. The results were validated in a second independent study.ResultsIntraclass correlation coefficients for between-day and technical repeatability were 0.93 and 0.96, respectively. Bland-Altman analysis showed good within-day repeatability. Correct classification rate of CF (n=53) vs healthy subjects (n=31) was 96% (R(2)=0.84; Q(2)=0.79). Model validation with a testing sample set obtained from subjects not included in the primary analysis (23 CF and 25 healthy subjects) showed a sensitivity of 91% and a specificity of 96%. The classification rate of stable CF (n=29) vs unstable CF patients (n=24) was 95% (R(2)=0.82; Q(2)=0.78). Model external validation in 14 patients with stable CF and 16 with unstable CF showed a sensitivity of 86% and a specificity of 94%. Ethanol, acetate, 2-propanol and acetone were most discriminant between patients with CF and healthy subjects, whereas acetate, ethanol, 2-propanol and methanol were the most important metabolites for discriminating between patients with stable and unstable CF.ConclusionsNuclear magnetic resonance spectroscopy of exhaled breath condensate is reproducible, discriminates patients with CF from healthy subjects and patients with unstable CF from those with stable CF, and identifies the metabolites responsible for between-group differences.
Paolo Montuschi; Debora Paris; Dominique Melck; Vincenzina Lucidi; Giovanni Ciabattoni; Valeria Raia; Cecilia Calabrese; Andrew Bush; Peter J Barnes; Andrea Motta
Related Documents :
20331856 - Near-infrared spectroscopy during stagnant ischemia estimates central venous oxygen sat...
24692376 - Misdiagnosis of common variable immune deficiency.
25218876 - A pilot randomized crossover trial assessing the safety and short-term effects of pomeg...
10270476 - Definitive criteria for prescribing home oxygen systems.
19128846 - Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent pre...
22898536 - Clinicopathological characteristics and outcomes of male lupus nephritis in china.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-21
Journal Detail:
Title:  Thorax     Volume:  -     ISSN:  1468-3296     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417353     Medline TA:  Thorax     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Pharmacology, Catholic University of the Sacred Heart, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epi...
Next Document:  Attitudes to participation in a lung cancer screening trial: a qualitative study.